PP
TXG icon

PDT Partners’s 10x Genomics TXG Stock Holding History

PDT Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,219
Closed -$1.31M – 615
2025
Q4 		$1.31M Sell
80,219
-28,706
-26% -$434K 0.08% 313
2025
Q3 		$1.27M Sell
108,925
-390,965
-78% -$5.1M 0.08% 323
2025
Q2 		$5.79M Sell
499,890
-159,150
-24% -$1.45M 0.33% 78
2025
Q1 		$5.75M Buy
659,040
+304,082
+86% +$3.83M 0.41% 46
2024
Q4 		$5.1M Buy
354,958
+226,513
+176% +$3.57M 0.45% 28
2024
Q3 		$2.9M Sell
128,445
-133,435
-51% -$2.76M 0.26% 126
2024
Q2 		$5.09M Buy
261,880
+216,662
+479% +$5.67M 0.48% 26
2024
Q1 		$1.7M Sell
45,218
-65,806
-59% -$2.89M 0.16% 225
2023
Q4 		$6.21M Buy
111,024
+18,077
+19% +$787K 0.69% 11
2023
Q3 		$3.83M Buy
92,947
+19,561
+27% +$1.02M 0.48% 36
2023
Q2 		$4.1M Sell
73,386
-109
-0.1% -$5.9K 0.56% 30
2023
Q1 		$4.1M Buy
+73,495
New +$3.43M 0.56% 14
2022
Q1 		– Sell
-27,573
Closed -$4.11M – 1125
2021
Q4 		$4.11M Sell
27,573
-8,227
-23% -$1.26M 0.31% 85
2021
Q3 		$5.21M Buy
35,800
+6,900
+24% +$1.18M 0.37% 53
2021
Q2 		$5.66M Sell
28,900
-7,300
-20% -$1.32M 0.37% 41
2021
Q1 		$6.55M Sell
36,200
-6,201
-15% -$1.07M 0.47% 12
2020
Q4 		$6M Sell
42,401
-23,121
-35% -$3.36M 0.41% 61
2020
Q3 		$8.17M Sell
65,522
-15,378
-19% -$1.61M 0.54% 31
2020
Q2 		$7.22M Buy
+80,900
New +$6.3M 0.49% 69

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's TXG Position: Q1 2026 in Review

PDT Partners sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 80,219 shares — an estimated $1.31M sold.

PDT Partners first reported a position in TXG in Q2 2020 and held it in 19 quarters. The position peaked at $8.17M in Q3 2020. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • PDT Partners reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 80,219 10x Genomics shares in Q1 2026, an estimated $1.31M.
  • PDT Partners first reported a position in 10x Genomics in Q2 2020 and held it in 19 quarters.
  • PDT Partners's 10x Genomics position peaked at $8.17M in Q3 2020.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.